Your browser doesn't support JavaScript. Please upgrade to a modern browser or enable JavaScript in your existing browser.
Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
www.ahrq.gov

Figure 1. Benefits and Harms1 of Chemoprevention with Tamoxifen per 10,000 Women in Three Age Groups2

Graph shows the number of events caused on the X axis and the estimated 5-year risk of breast cancer on the Y axis. Go to Text Description [D] for details.

[D] Select for Text Description.

1Harms include endometrial cancer, stroke, and pulmonary embolism combined.
2Adapted from Gail et al, 1999(49).

Return to Contents
Return to Document

 

AHRQ Advancing Excellence in Health Care